Arthritis
Conditions
Keywords
Total Hip Replacement, Manipulation Therapy
Brief summary
Post-surgical physiotherapy programs following to total hip arthroplasty (THA) show important differences between types and numbers of treatment sessions. Objectives are to investigate effectiveness of Fascial Manipulation when associated to a standard protocol of care.
Detailed description
Background. Post-surgical physiotherapy programs following to total hip arthroplasty (THA) show important differences between types and numbers of treatment sessions. Objectives are to investigate effectiveness of Fascial Manipulation when associated to a standard protocol of care. Methods. Fifty-one subjects operated with THA were randomized into two groups, both followed a standard protocol of care where two sessions were replaced with Fascial Manipulation in the study group. Functional outcomes measures collected before and after treatment and at the end of the rehabilitation program included Harris Hip Score, Time Up and Go test, articular range of motion and verbal numerical scale.
Interventions
OTHERFascial Manipulation® (FM)
Fascial Manipulation® (FM) is a manual therapy that focus on the deep muscular fascia. This technique considers the fascia as a three-dimensional continuum. The mainstay of this manual technique lies in the identification of specific localised areas of the fascia, defined Center of Coordination (CC), where the gliding of the subcutis should be preserved to avoid biomechanical in-coordination of the surrounding muscles. The method is performed by applying a deep friction over the CCs that result more altered at the clinical palpation
OTHERstandard active exercises
two sessions of 45 minutes of active exercises
Sponsors
Azienda Ospedaliera Bolognini di Seriate Bergamo
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Healthy volunteers
Yes
Inclusion criteria
* first THA surgery, * posterior-lateral access, * onset of pain of maximum 2 years
Exclusion criteria
* patients with previous hip or knee prosthesis, * congenital hip dysplasia, * revision THA, * elective THA secondary to trauma, * real leg-length discrepancy (≥1.5cm), * cognitive impairment, * concomitant rheumatic pathology in acute phase, * serious comorbidities including cardiac, * respiratory and/or neuromuscular pathologies.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change of pain during movement | change from before and after the 2nd day treatment, change from before and after the 7nd day treatment, change from 2nd and 10th day (end of study) | value of pain during a specific movement , measured with Visual Numeric Scale (VNS) scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Range of motion (ROM) | before and after the 2nd day treatment, before and after the 7nd day treatment, 10th day (end of study) | hip ROM amplitude, measured with bobble inclinometer |
| Harris Hip Score | before and after the 2nd day treatment, before and after the 7nd day treatment, 10th day (end of study) | Functional outcome |
| Timed up and Go test (TuG) | before and after the 2nd day treatment, before and after the 7nd day treatment, 10th day (end of study) | functional test for stand up and walk speed |
Outcome results
None listed